miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Hepatology

Original research

miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Xu W, Liu J, Feng J, et al

miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy

Gut 2020;69:1309-1321.